Federal
Safe and Affordable Drugs from Canada Act of 2019
Source: Congress.gov Β·
1,102 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
1ST SESSION
H. R. 478
To amend the Federal Food, Drug, and Cosmetic Act to allow for the
personal importation of safe and affordable drugs from approved phar-
macies in Canada.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 10, 2019
Ms. PINGREE (for herself and Ms. HERRERA BEUTLER) introduced the
following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to
allow for the personal importation of safe and affordable
drugs from approved pharmacies in Canada.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ββSafe and Affordable
4
Drugs from Canada Act of 2019ββ.
5
SEC. 2. SAFE AND AFFORDABLE DRUGS FROM CANADA.
6
Chapter VIII of the Federal Food, Drug, and Cos-
7
metic Act (21 U.S.C. 381 et seq.) is amended by adding
8
at the end the following:
9
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
2
β’HR 478 IH
ββSEC. 810. IMPORTATION BY INDIVIDUALS OF PRESCRIP-
1
TION DRUGS FROM CANADA.
2
ββ(a) IN GENERAL.βNotwithstanding any other pro-
3
vision of this Act, not later than 180 days after the date
4
of enactment of this section, the Secretary shall promul-
5
gate regulations permitting individuals to safely import
6
into the United States a prescription drug described in
7
subsection (b).
8
ββ(b) PRESCRIPTION DRUG.βA prescription drug de-
9
scribed in this subsectionβ
10
ββ(1) is a prescription drug thatβ
11
ββ(A) is purchased from an approved Cana-
12
dian pharmacy;
13
ββ(B) is dispensed by a pharmacist licensed
14
to practice pharmacy and dispense prescription
15
drugs in Canada;
16
ββ(C) is purchased for personal use by the
17
individual, not for resale, in quantities that do
18
not exceed a 90-day supply;
19
ββ(D) is filled using a valid prescription
20
issued by a physician licensed to practice in a
21
State in the United States; and
22
ββ(E) has the same active ingredient or in-
23
gredients, route of administration, dosage form,
24
and strength as a prescription drug approved
25
by the Secretary under chapter V; and
26
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
3
β’HR 478 IH
ββ(2) does not includeβ
1
ββ(A) a controlled substance (as defined in
2
section 102 of the Controlled Substances Act
3
(21 U.S.C. 802));
4
ββ(B) a biological product (as defined in
5
section 351 of the Public Health Service Act
6
(42 U.S.C. 262));
7
ββ(C) an infused drug (including a peri-
8
toneal dialysis solution);
9
ββ(D) an intravenously injected drug;
10
ββ(E) a drug that is inhaled during surgery;
11
ββ(F) a parenteral drug;
12
ββ(G) a drug manufactured through one or
13
more biotechnology processes, includingβ
14
ββ(i) a therapeutic DNA plasmid prod-
15
uct;
16
ββ(ii) a therapeutic synthetic peptide
17
product of not more than 40 amino acids;
18
ββ(iii) a monoclonal antibody product
19
for in vivo use; and
20
ββ(iv) a therapeutic recombinant DNA-
21
derived product;
22
ββ(H) a drug required to be refrigerated at
23
any time during manufacturing, packing, proc-
24
essing, or holding; or
25
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
4
β’HR 478 IH
ββ(I) a photoreactive drug.
1
ββ(c) APPROVED CANADIAN PHARMACY.β
2
ββ(1) IN
GENERAL.βIn this section, an ap-
3
proved Canadian pharmacy is a pharmacy thatβ
4
ββ(A) is located in Canada; and
5
ββ(B) that the Secretary certifiesβ
6
ββ(i) is licensed to operate and dis-
7
pense prescription drugs to individuals in
8
Canada; and
9
ββ(ii) meets the criteria under para-
10
graph (3).
11
ββ(2) PUBLICATION
OF
APPROVED
CANADIAN
12
PHARMACIES.βThe Secretary shall publish on the
13
internet website of the Food and Drug Administra-
14
tion a list of approved Canadian pharmacies, includ-
15
ing the internet website address of each such ap-
16
proved Canadian pharmacy, from which individuals
17
may purchase prescription drugs in accordance with
18
subsection (a).
19
ββ(3) ADDITIONAL
CRITERIA.βTo be an ap-
20
proved Canadian pharmacy, the Secretary shall cer-
21
tify that the pharmacyβ
22
ββ(A) has been in existence for a period of
23
at least 5 years preceding the date of such cer-
24
tification and has a purpose other than to par-
25
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
5
β’HR 478 IH
ticipate in the program established under this
1
section;
2
ββ(B) operates in accordance with phar-
3
macy standards set forth by the provincial
4
pharmacy rules and regulations enacted in Can-
5
ada;
6
ββ(C) has processes established by the phar-
7
macy, or participates in another established
8
process, to certify that the physical premises
9
and data reporting procedures and licenses are
10
in compliance with all applicable laws and regu-
11
lations, and has implemented policies designed
12
to monitor ongoing compliance with such laws
13
and regulations;
14
ββ(D) conducts or commits to participate in
15
ongoing and comprehensive quality assurance
16
programs and implements such quality assur-
17
ance measures, including blind testing, to en-
18
sure the veracity and reliability of the findings
19
of the quality assurance program;
20
ββ(E) agrees that laboratories approved by
21
the Secretary shall be used to conduct product
22
testing to determine the safety and efficacy of
23
sample pharmaceutical products;
24
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
6
β’HR 478 IH
ββ(F) has established, or will establish or
1
participate in, a process for resolving grievances
2
and will be held accountable for violations of es-
3
tablished guidelines and rules;
4
ββ(G) does not resell products from online
5
pharmacies located outside Canada to cus-
6
tomers in the United States; and
7
ββ(H) meets any other criteria established
8
by the Secretary.ββ.
9
Γ
VerDate Sep 11 2014
02:14 Jan 25, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H478.IH
H478
pamtmann on DSKBFK8HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.